Benjamin Ascher

A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines

Benjamin Ascher, Benjamin Zakine, Philippe Kestemont et al. · Journal of the American Academy of Dermatology · 2004 · 182 citations

Microbial Toxin, Glabellar Lines, Botulinum Toxin A +3

Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crow's Feet

Nicholas J. Lowe, Benjamin Ascher, Marc Heckmann et al. · Dermatologic Surgery · 2006 · 123 citations

Efficacy, patient‐reported outcomes and safety profile of <scp>ATX</scp>‐101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase <scp>III</scp>, randomized, placebo‐controlled study

Benjamin Ascher, Klaus Hoffmann, Patricia Walker et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 117 citations · Full text

International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part II: wrinkles on the middle and lower face, neck and chest

Benjamin Ascher, Sérgio Talarico, Daniel Cassuto et al. · Journal of the European Academy of Dermatology and Venereology · 2010 · 109 citations · Full text

International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) – part I: upper facial wrinkles

Benjamin Ascher, Sérgio Talarico, Daniel Cassuto et al. · Journal of the European Academy of Dermatology and Venereology · 2010 · 106 citations · Full text